Sickle cell disease is more than a medical diagnosis, it is a life-altering condition that weaves itself into every thread of daily life.In families where one or more members live with the disease, ...

It is one hour at a time for Gladicy Mbeyu, a sickle cell warrior who was last year awarded a state commendation for helping ...

The study included 88 teens with sickle cell disease, who were followed at the Nationwide Children’s Hospital in Ohio for at ...

Experts make case for early testing, prevention and care In this report, VINCENT KURAUN explores the groundbreaking ...

Larenz Lamaar Fondren was two weeks away from graduating as a licensed vocational nurse, a dream shaped by a lifetime of battling sickle cell anemia.The 19-year-old planned on pursuing a career as a ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Medical advances are changing some of the hallmark physical symptoms of sickle cell disease, columnist Oluwatosin Adesoye ...

Tutu, a pediatrician at the Komfo Anokye Teaching Hospital (KATH), has emphasised the critical need for evidence-based ...

The Michigan Sickle Cell Data Collection Program has been tracking information from the estimated 4,000 Michigan residents ...

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.

But not if you suffer from sickle cell disease, which affects nearly eight million people worldwide, most in sub-Saharan Africa. In the UK, approximately 17,500 people have sickle cell disease and ...

Funmi Dasaolu receives funding from The National Institute for Health and Care Research. Stephen Hibbs receives funding from the Wellcome Trust. In December 2023, 34-year-old Dave Onawelo told ...